Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase <scp>II</scp> Study

Authors

Institutions

Publication Details

Journal
Thoracic Cancer
Published
2025-04-01
DOI
https://doi.org/10.1111/1759-7714.70055
Citations
3
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
6.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study

Jingni Zhu, Jiamin Shi, Fei Yan, Delin Liu et al.
3 citations
Thoracic Cancer
Esophageal Cancer Research and Treatment
6.02
article

Polymeric Micellar Paclitaxel Plus Cisplatin Combined With Tislelizumab as the First‐Line Treatment of Advanced Unresectable Esophageal Squamous Cell Carcinoma: A Phase II Study

Jingni Zhu, Jiamin Shi, Fei Yan, Delin Liu, Xiaoyou Li, Guochun Cao, Jinghua Zhu
article en
3 citations

Abstract

No abstract available for this paper.
Thoracic CancerVol. 16(7)
Jiangsu Cancer Hospital (CN), Nanjing Medical University (CN)
Jiangsu Cancer Hospital
Openalex Percentile: Top 4%
Esophageal Cancer Research and Treatment
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.